Keywords: sharp, decline, third-quarter, net, income, lilly, prozac

Sharp decline in third-quarter 2001 net income for Lilly as Prozac sales

Article | 19 October 2001

Print This

Eli Lilly has posted a 7% decline in net income for the third quarter of2001 to $723.2 million, or $0.66 per share, noting ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in